Institut Paoli-Calmettes
Marseille's cancer centre, strong in haematology and transplantation, pancreatic surgery, breast cancer and immuno-oncology research.
Founded in 1925, the Institut Paoli-Calmettes is the UNICANCER comprehensive cancer centre for Provence-Alpes-Côte d'Azur. Its research arm is the Centre de Recherche en Cancérologie de Marseille (CRCM, with Inserm, CNRS and Aix-Marseille Université), and it belongs to the Marseille Immunopôle cluster alongside the Centre d'Immunologie de Marseille-Luminy. Clinical strengths include a major allogeneic transplant and leukaemia programme, high-volume pancreatic and hepatobiliary surgery, breast oncology under Anthony Gonçalves, and an early-phase unit. It runs a large tumour biobank and a molecular profiling programme for patients across the region.
- Haematology and allogeneic transplant
- Pancreatic surgery
- Breast oncology
- Early-phase trials
- Marseille Immunopôle
Pages like this
not linked directly; found by shared links- TargetCD70
Shares Allogeneic (off-the-shelf) cell therapy, Acute myeloid leukaemia, CAR-T cell therapy.
- PersonStephen J. Forman
Shares Allogeneic (off-the-shelf) cell therapy, Acute myeloid leukaemia, CAR-T cell therapy.
- TargetCD7
Shares Allogeneic (off-the-shelf) cell therapy, Acute myeloid leukaemia, CAR-T cell therapy.
- InstitutionHamad Medical Corporation / National Center for Cancer Care and Research
Shares Allogeneic (off-the-shelf) cell therapy, Acute myeloid leukaemia, HR-positive / HER2-negative breast cancer.
- InstitutionRamathibodi Hospital, Mahidol University
Shares Allogeneic (off-the-shelf) cell therapy, Acute myeloid leukaemia, HR-positive / HER2-negative breast cancer.
- PersonChristophe Le Tourneau
Shares UNICANCER, Comprehensive genomic profiling.
- InstitutionChristian Medical College, Vellore
Shares Allogeneic (off-the-shelf) cell therapy, Acute myeloid leukaemia, CAR-T cell therapy.
- InstitutionInstitut Bergonié
Shares UNICANCER, Comprehensive genomic profiling, HR-positive / HER2-negative breast cancer.